Recent news on Latanoprost

Comparing Bimatoprost Daily versus Every Two Days in Patients With ...  -  May 15, 2007
DG NewsThese results are not unlike what has been seen with other prostaglandin analogs -- travoprost and latanoprost -- both of which show a statistically

Glaucoma Experts Determine That Reducing Intraocular Pressure ...  -  May 11, 2007
Medical News Today (press release),A retrospective analysis of the Xalatan Lumigan Travatan (XLT) study show that three prostaglandins, latanoprost, bimatoprost and travoprost reduce the

NicOx Announces that Pfizer has Disclosed Further Details of ...  -  Mar 29, 2007
Drug Newswire (press release),Pfizer specify that this trial is a phase 2, dose-finding study, which is designed to compare the safety and the efficacy of PF-03187207 to latanoprost.

Pfizer spies pSivida's injectable eye treatment  -  Apr 4, 2007
DrugResearcher.com,Pfizer already has a few ophthalmic products on the market, Xalatan (latanoprost) for open-angle glaucoma or ocular hypertension, and Macugen (pegaptanib

ISTA Pharmaceuticals Reports 2006 Financial Results  -  Mar 6, 2007
PR Newswire (press release),...a new formulation of latanoprost, and bepotastine * Initiated and completed Phase III studies for Xibrom once-daily formulation and initiated Xibrom

NicOx presents promising pre-clinical results on an NOdonating ...  -  Feb 13, 2007
PipelineReview.com (press release),The results presented jointly by NicOx and Pfizer relate to a compound from a series of nitric oxide-donating derivatives of latanoprost that have been

Mergers, Acquisitions, etc.  -  Feb 16, 2007
OSN SuperSite (subscription),Akorn officials expect the drugs — generic equivalents versions of latanoprost, bimatoprost and travoprost — to be manufactured by South Korea-based Taejoon

(PRN) - Calamos Asset Management, Inc. Announces Assets Under ...  -  Feb 12, 2007
Bolsamania.com,...(PRN) - NicOx Presents Promising Pre-Clinical Results on an NO-Donating Latanoprost Derivative From Its Glaucoma Collaboration With Pfizer ... [+]

Biovitrum and Synphora Initiate Phase II Study of Psoriasis Treatment  -  Feb 5, 2007
PharmaLive.com (press release),Drug Development, and Bahram Resul, Associate Professor of Medicinal Chemistry, are the inventors of latanoprost, the active principle of Xalatan(R).

Biovitrum and Synphora Initiate Phase II Study of Psoriasis Treatment  -  Feb 5, 2007
Business Wire (press release),Professor of Pharmacology and Drug Development, and Bahram Resul, Associate Professor of Medicinal Chemistry, are the inventors of latanoprost,

Akorn, Azad Partner on 3 Glaucoma Drugs  -  Jan 9, 2007
Forbes,The three ophthalmic ANDA drugs, Latanoprost, Bimatoprost and Travoprost, are expected to be manufactured by Taejoon Pharmaceutical Co.

Akorn and Azad Ink Gluacoma Deal  -  Jan 9, 2007
Genetic Engineering News (press release),The companies report that the products, Latanoprost, Bimatoprost, and Travoprost, have a total US market-size of $870 million, according to 2006 IMS data.

Market Report -- In Play (AKN)  -  Jan 9, 2007
MSN Money...with Azad Pharma to develop and supply Latanoprost, Bimatoprost and Travoprost, three ophthalmic ANDA drug products for the treatment of glaucoma.

Biovitrum Enters Development Agreement with Swedish Biotech ...  Oct 10, 2006
Professor of Pharmacology and Drug Development, and Bahram Resul, Associate Professor of Medicinal Chemistry, are the inventors of latanoprost, the active ... -WebWire (press release), Allergan Gets FDA Nod For Eye Drop LUMIGAN As First-line Treatment ...  Jun 23, 2006
Ista will pay $16 million up-front for glaucoma treatments iganidipine, a calcium channel blocker, and prostaglandin, a new formulation of latanoprost. ... -Trading Markets

Allergan Announces FDA Approval of LUMIGAN(R) As First-Line ...  Jun 23, 2006
A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension ... -International News Service



Study Demonstrates Benefits of Combination Treatment for Glaucoma  May 11, 2006
MONTREAL, CANADA -- May 11, 2006 -- Preliminary results from the Canadian EXACCT study (Evaluation of latanoprost (Xalatan) and Cosopt® in Combination or ... - DG News

NEW STUDY DEMONSTRATES A SINGLE COMPOUND AS EFFECTIVE AS A FIXED ...  May 3, 2006
...analogue LUMIGAN (bimatoprost) is as effective alone at lowering intraocular pressure (IOP) as a fixed combination (XALACOM) of latanoprost (Xalatan) combined ... - ITNews

Glaucoma treatment has options  Apr 23, 2006
...levobunolol (Betagan) or timolol (Betimol, Timoptic) can reduce the production of aqueous humor, and prostaglandin analogues such as latanoprost (Xalatan) can ... - Fort Wayne Journal Gazette





Santen Pharmaceutical Announces Results of Overseas Clinical ...  Feb 15, 2006
...demonstrated an eye pressure-lowering effect, but any favorable result was obtained from a non-inferiority study in which DE-085 was compared with latanoprost. ... - Japan Corporate News,

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional